MedTrace Logo

BRCA Founder OutReach (BFOR) Study

NCT03351803 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5412

Last updated 2026-03-06

No results posted yet for this study

Summary

The purpose of this study is to learn how to provide BRCA gene testing to a larger number of people as well as to make testing part of a person's regular medical care.

Conditions

  • BRCA1 Mutation
  • BRCA2 Mutation

Interventions

OTHER

BFOR Digital Health solution/Web Portal

A digital health solution with Internet-based participant recruitment and ascertainment is a mechanism for distributing access to genetic testing to populations who might not otherwise have access. For this project, LifeLink will build a private web-portal designed by the PI's of the study as described in this protocol, including the wireframes that are in the appendices, that will enable secure contact between study participants and the participating commercial laboratory (Quest Diagnostics) and BFOR researchers, as well as facilitate contacts between study participants and their primary care providers and/or a list of BFOR study centers and BFOR providers.

Sponsors & Collaborators

Principal Investigators

  • Kenneth Offit, MD, MPH · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-11-10
Primary Completion
2026-05-10
Completion
2026-05-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03351803 on ClinicalTrials.gov